BG61592B1 - Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му - Google Patents

Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му Download PDF

Info

Publication number
BG61592B1
BG61592B1 BG99252A BG9925294A BG61592B1 BG 61592 B1 BG61592 B1 BG 61592B1 BG 99252 A BG99252 A BG 99252A BG 9925294 A BG9925294 A BG 9925294A BG 61592 B1 BG61592 B1 BG 61592B1
Authority
BG
Bulgaria
Prior art keywords
weight
core
layer
active agent
tablet
Prior art date
Application number
BG99252A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99252A (en
Inventor
Pal Fekete
Geb. Ignacz Maria Kiraly
Gabor Sipos
Geb. Hoffmann Zsuzsanna Jambor
Gyoergy Ujfalussy
Geb. Hernyes Magdolna Gora
Imre Klebovich
Sandor Drabant
Attila Mandi
Geb. Szabo Gizella Kiss
Erzsebet Barczay
Maria Kriszitian
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of BG99252A publication Critical patent/BG99252A/bg
Publication of BG61592B1 publication Critical patent/BG61592B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG99252A 1993-12-09 1994-12-09 Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му BG61592B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9303504A HU213407B (en) 1993-12-09 1993-12-09 Process for producing tablet with diffusive-osmotic release

Publications (2)

Publication Number Publication Date
BG99252A BG99252A (en) 1995-09-29
BG61592B1 true BG61592B1 (bg) 1998-01-30

Family

ID=10984230

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99252A BG61592B1 (bg) 1993-12-09 1994-12-09 Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му

Country Status (21)

Country Link
US (1) US5543155A (it)
EP (1) EP0662321B1 (it)
JP (1) JPH07277957A (it)
KR (1) KR950016714A (it)
AT (1) ATE185693T1 (it)
BE (1) BE1009867A3 (it)
BG (1) BG61592B1 (it)
CA (1) CA2137426A1 (it)
CZ (1) CZ288014B6 (it)
DE (1) DE69421263T2 (it)
ES (1) ES2114423B1 (it)
FR (1) FR2713484B1 (it)
GR (1) GR1002349B (it)
HR (1) HRP940979A2 (it)
HU (1) HU213407B (it)
IT (1) IT1271122B (it)
PL (1) PL306181A1 (it)
RU (1) RU2133605C1 (it)
SK (1) SK279735B6 (it)
UA (1) UA34458C2 (it)
YU (1) YU71894A (it)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
SI9500173B (sl) * 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
WO1997039116A1 (en) * 1996-04-12 1997-10-23 Novo Nordisk A/S Enzyme-containing granules and process for the production thereof
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
KR100522248B1 (ko) * 1997-05-29 2006-02-01 동아제약주식회사 이중제어방출막구조의경구서방성제제및그제조방법
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
JP2002531491A (ja) 1998-12-11 2002-09-24 ノストラム・ファーマスーティカルズ・インコーポレイテッド ヒドロコロイドおよびセルロースエーテルを含む持続放出性錠剤
RU2160096C1 (ru) * 1999-07-19 2000-12-10 ООО "БиоДом" Субстанция липовитам е, обладающая антиоксидантной активностью, и витаминный комплекс
EP1967185A1 (en) * 1999-12-23 2008-09-10 Pfizer Products Inc. Hydrogel-driven drug dosage form
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
DE60123384T2 (de) 2000-02-04 2007-08-02 DepoMed, Inc., Menlo Park Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
US6268368B1 (en) * 2000-03-01 2001-07-31 American Pharmaceuticals International Anionic exchange polymer complexes of buspirone
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
GB0007419D0 (en) * 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20040062787A1 (en) * 2001-12-17 2004-04-01 Daley William Lionel Therapeutic combination of amlodipineand benazepril/benazeprilat
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
RU2325152C2 (ru) * 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
US6419903B1 (en) * 2001-08-20 2002-07-16 Colgate Palmolive Company Breath freshening film
IN191024B (it) * 2001-09-25 2003-09-13 J B Chemicals And Pharmaceutic
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US8329217B2 (en) * 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
RU2203044C1 (ru) * 2001-12-27 2003-04-27 Закрытое акционерное общество "Брынцалов-А" Антидепрессант амитриптилин-ферейн
NZ534039A (en) 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法
PE20050335A1 (es) * 2003-08-07 2005-06-01 Sb Pharmco Inc Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion
EP1761265A2 (en) * 2004-06-28 2007-03-14 ALZA Corporation A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
GB2421431B (en) * 2004-12-24 2007-10-10 Aquasol Ltd Dosing systems
WO2006123357A2 (en) * 2005-02-22 2006-11-23 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
JP2009507774A (ja) * 2005-08-04 2009-02-26 アルザ・コーポレーシヨン 改良された性質を提供するポリマー混合物による半透過性膜を含んでなる浸透性用量形態物
US20070128282A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20070128281A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US20070128280A1 (en) * 2005-12-02 2007-06-07 Patel Hasmukh B Oral osmotic drug delivery system
US7419684B2 (en) * 2006-12-22 2008-09-02 Reliant Pharmaceuticals, Inc. System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
US7714201B2 (en) * 2006-12-22 2010-05-11 Monsanto Technology Llc Cotton variety 781000G
US20110142905A1 (en) * 2008-08-14 2011-06-16 Bioneer A/S Coated tablets with remaining degradation surface over the time
AR076907A1 (es) * 2009-05-13 2011-07-20 Wyeth Llc Composiciones con liberacion rapida de farmaco
US9861585B2 (en) 2012-10-16 2018-01-09 Sun Pharmaceutical Industries Limited Osmotic floating tablets
CN104721051B (zh) * 2014-12-17 2018-03-20 镇江杏林医疗科技有限公司 理疗贴及其柱形膏的制作方法
AU2016272089B2 (en) 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
EP3573602A4 (en) 2017-01-26 2020-09-16 Triastek, Inc. DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
DE3438291A1 (de) * 1984-10-19 1986-04-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release

Also Published As

Publication number Publication date
HU9303504D0 (en) 1994-04-28
PL306181A1 (en) 1995-06-12
CZ309994A3 (en) 1995-07-12
EP0662321B1 (en) 1999-10-20
BG99252A (en) 1995-09-29
HU213407B (en) 1997-06-30
JPH07277957A (ja) 1995-10-24
GR1002349B (el) 1996-05-29
CZ288014B6 (cs) 2001-04-11
IT1271122B (it) 1997-05-26
RU94043798A (ru) 1996-11-10
US5543155A (en) 1996-08-06
EP0662321A1 (en) 1995-07-12
ITMI942484A0 (it) 1994-12-09
ITMI942484A1 (it) 1996-06-09
CA2137426A1 (en) 1995-06-10
BE1009867A3 (fr) 1997-10-07
RU2133605C1 (ru) 1999-07-27
KR950016714A (ko) 1995-07-20
SK152494A3 (en) 1995-07-11
UA34458C2 (uk) 2001-03-15
DE69421263D1 (de) 1999-11-25
HRP940979A2 (en) 1997-02-28
ATE185693T1 (de) 1999-11-15
DE69421263T2 (de) 2000-05-11
HUT69397A (en) 1995-09-28
ES2114423B1 (es) 1999-07-01
SK279735B6 (sk) 1999-03-12
FR2713484A1 (fr) 1995-06-16
ES2114423A1 (es) 1998-05-16
YU71894A (sh) 1997-03-07
FR2713484B1 (fr) 1997-12-12

Similar Documents

Publication Publication Date Title
BG61592B1 (bg) Нов дифузионно-осмотичен фармацевтичен състав с контролирано освобождаване на лекарството и метод за получаването му
US6537573B2 (en) Combination dosage form comprising cetirizine and pseudoephedrine
CN100402021C (zh) 包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)苯酚并能提供活性成分的延迟释放的药物
RU2179017C2 (ru) Фармацевтическая композиция для контролируемого высвобождения активных веществ (варианты) и способ ее получения (варианты)
AU622273B2 (en) Medicaments having controlled release of the active compound
JP2007521231A (ja) 塩酸ブプロピオンの放出調節錠剤
MX2010008861A (es) Tableta oral de liberacion controlada con efecto de liberacion masiva reducido.
IE63764B1 (en) Controlled release device with an impermeable coating having an orifice for release of drug
AU2002359582B2 (en) Extended release pharmaceutical tablet of metformin
BG107372A (bg) Препарати със забавено действие на хинолонови антибиотици и метод за получаването им
IE69174B1 (en) A system for the controlled release of active agents and a process for its preparation
EP2521537A2 (en) Pharmaceutical composition for modified delivery of actives
US20040058000A1 (en) Controlled release capsule for delivery of liquid formulation
CA2554874A1 (en) Methods of reducing alcohol-induced dose dumping for hydromorphone sustained release oral dosage forms
KR20050032510A (ko) 4-아미노-6,7-디메톡시-2-(5-메탄설폰아미도-1,2,3,4-테트라하이드로이소퀴놀-2-일)-5-(2-피리딜)퀴나졸린의 제어방출을 위한 약학적 제형
JP2011140510A (ja) 塩酸ブプロピオンの放出調節錠剤
JPWO1993006821A1 (ja) 徐放性錠剤